Betamethasone Dipropionate

倍他米松二丙酸酯

Report date: 2023/03/15 17:55:18
NME

Base Information

Drug NameBetamethasone Dipropionate
Drug Alias Name二丙酸倍他米松DiprosoneRinderon-DPDiprolene AFSernivo +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasisPsoriasisPruritus +[7] 
Global Approved IndicationsPruritusEczemaDermatitis
Approved Indications in ChinaPruritusDermatitis
Original Approved Country/TerritoryUnited States
Original Approved Date1975/01/29
Country/TerritoryCanadaUnited StatesAustralia +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShionogi & Co LtdMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrimus Pharmaceuticals IncMerck Canada IncHikma Pharmaceuticals +[7] 
Inactive CompaniesSchering Ag
Active IndicationsPsoriasisPruritusEczema +[6] 
Inactive IndicationsPlaque psoriasis

Other Information

ATC CodeA07EA04C05AA05D07AC01 +[11] 
Related LinksWikipediaDrugBankKEGG